|
List
by Protocol Number
Informational
NCCTG N0392
Consent
HIPAA
Protocol
Assessment of Patient Satisfaction with Participation in Phase II/III NCCTG
Clinical Trials
NSABP DMP1
Consent
HIPAA
Protocol
Fast Facts
A Study to Evaluate
Different Decision-making Approaches Used by Women Known to be at Increased Risk
for Breast Cancer
Symptom Management
Joint Pain
SWOG S0927 Consent
HIPAA
Protocol
(hold for
SWOG opening)
A Randomized Placebo-Controlled Trial of
Omega-3-Fatty Acid for the Control of Aromatase
Inhibitor-Induced Musculoskeletal Pain and
Stiffness in Women with Early Stage Breast
Cancer, Phase III
Vaginal Symptoms
NCCTG N10C1 Consent HIPAA Protocol
Vaginal DHEA for Vaginal Symptoms: A Phase III
Randomized, Double Blind, Placebo-Controlled
Trial
Hot Flashes
NCCTG N10C2 Consent
HIPAA
Protocol
Double-Blind, Placebo-Controlled Study of
Magnesium Supplements to Reduce Menopausal Hot
Flashes
Neuropathy
CTSU N08CB
Consent
HIPAA Schema
Protocol
A
Phase III Randomized, Placebo-Controlled,
Double-Blind Study of Intravenous
Calcium/Magnesium in Two Different Versions to
Prevent Oxaliplatin-Induced Sensory
Neurotoxicity
Mucositis
NCCTG N09C6 Consent
HIPAA
Protocol
Randomized Double-Blind Study of Doxepin Rinse
versus Placebo in the Treatment of Acute Oral
Mucositis Pain in Patients Receiving
Radiotherapy with or without Chemotherapy
Erectile
Dysfunction
RTOG R0831
Consent
QOL
Consent
HIPAA
Protocol
(Permanent
closure 2/17/12)
A Randomized,
Double-Blinded, Placebo-Controlled Phase III
Trial to Evaluate the Effectiveness of a
Phosphodiesterase 5 Inhibitor, Tadalafil, in
Prevention of Erectile Dysfunction in Patients
Treated With Radiotherapy for Prostate Cancer
Cardio-toxicity
CTSU SCUSF0806
Consent
HIPAA Protocol
Schema
Phase II
Placebo-controlled Trial of Lisinopril and Coreg CR to Reduce Cardiotoxicity in
Patients with Breast Cancer Receiving (neo)Adjuvant Chemotherapy with
Trastuzumab
Bone
SWOG S0702
Consent
HIPAA
Fast Facts Protocol
A Prospective Observational Multicenter
Cohort Study to Assess the Incidence of
Osteonecrosis of the Jaw (ONJ) in Cancer
Patients with Bone Metastases Starting
Zoledronic Acid Treatment
CTSU C70604 Consent
HIPAA
Schema
Protocol
Treatment calendar Arm A
Arm B
A Randomized, Phase III Study of Standard Dosing
versus Longer Dosing Interval of Zoledronic Acid
in Metastatic Cancer
Radiation
Oncology
RTOG R0933
Consent
HIPAA
Protocol
A Phase II Trial of
Hippocampal Avoidance During Whole-Brain
Radiotherapy for Brain Metastasis
NCCTG N08C9 Consent
HIPAA
Protocol
Phase
III, Randomized, Study of Sulfasalazine versus
Placebo in the Prevention of Acute Diarrhea in
Patients Receiving Pelvic Radiation Therapy
|
